ArticleFrontiers in medicine2020

Determination of a "Specific Population Who Could Benefit From Rosuvastatin": A Secondary Analysis of a Randomized Controlled Trial to Uncover the Novel Value of Rosuvastatin for the Precise Treatment of ARDS.

Shi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.